Price Band
₹128 - ₹135
Lot Size
1000
Issue Size
₹37.67 Cr
GMP
N/A
Subscription
1.79x
Analyzing...
IPO Schedule
1
Open
27 May 2025
2
Close
29 May 2025
3
Allotment
-
4
Listing
3 Jun 2025
About Astonea Labs
Astonea Labs is an SME focused on the manufacturing and distribution of pharmaceutical intermediates and active pharmaceutical ingredients (APIs). They cater to both domestic and international markets, with a focus on niche therapeutic areas.
Key Strengths
- High Return on Equity (ROE) of 37.86% indicates efficient utilization of shareholder equity.
- Established presence in the pharmaceutical intermediates and APIs market.
- Diversified customer base across domestic and international markets reduces dependency on a single region.
- Focus on niche therapeutic areas allows for higher margins and less competition.
- Experienced management team with a proven track record in the pharmaceutical industry.
Risk Factors
- •SME segment IPOs are inherently more volatile and carry higher risk compared to mainboard IPOs.
- •The pharmaceutical industry is subject to stringent regulatory requirements, impacting operations and profitability.
- •Dependence on key suppliers for raw materials can expose the company to supply chain disruptions and price fluctuations.
Valuation Analysis
The P/E ratio of 27.36 appears reasonable considering the high ROE, but investors should carefully evaluate the risks associated with SME IPOs and the overall market sentiment before investing.
IPO Details
ExchangeBSE
SegmentSME
ISININE0TG901011
Face Value₹10
Lot Size1000
Issue Size₹37.67 Cr
Key Metrics
ROE37.86%
ROCE22.95%
P/E Ratio27.36
Industry P/E20
EPS4.93
PAT Margin4.75%
Debt/Equity2.16
Growth & Quality
ProfitableYes ✓
Subscription
Total0.22x
Imbalance Ratio121.0x
Documents
RHP not available
Key Dates
Open Date27 May 2025
Close Date29 May 2025
Listing3 Jun 2025